InvestorsHub Logo
Followers 196
Posts 24699
Boards Moderated 0
Alias Born 04/03/2010

Re: skitahoe post# 678552

Thursday, 03/14/2024 8:35:54 PM

Thursday, March 14, 2024 8:35:54 PM

Post# of 701422
When Keytruda came out...

https://www.fiercepharma.com/pharma/updated-merck-s-melanoma-game-changer-keytruda-likely-to-bolster-drug-pricing-debate

$150,000 per year, and typically patients took it for up to 2 years.

2014 prices.

Obviously insurance covers a large part of it.

Optune is 21,000 per month, indefinitely, and where it is covered, insurance covers some large portion of that. That is $252,000 per year.

In my opinion, DCVax-L, even priced as is, or more, is not only better, but comes out way cheaper per month, likely. Especially if they charge some decent portion of it over time.

And Car-T is way more all in, including side-effects, hospital care and all of the ancillary costs that don't get included by some.

I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News